These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
6. Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial. Sun Y; Lv Q; Guo Y; Wang Z; Huang R; Gao X; Han Y; Yao Z; Zheng M; Luo S; Li Y; Gu X; Zhang Y; Wang J; Hong L; Ma X; Su G; Sheng J; Lai C; Shen A; Wang M; Zhang W; Wu S; Zheng Z; Li J; Zhong T; Wang Y; He L; Du X; Ma CS J Am Coll Cardiol; 2024 Nov; 84(20):2037-2047. PubMed ID: 39505412 [TBL] [Abstract][Full Text] [Related]
7. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
8. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702 [TBL] [Abstract][Full Text] [Related]
9. Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial. Biccirè FG; Kakizaki R; Koskinas KC; Ueki Y; Häner J; Shibutani H; Lønborg J; Spitzer E; Iglesias JF; Otsuka T; Siontis GCM; Stortecky S; Kaiser C; Ambühl M; Morf L; Ondracek AS; van Geuns RJ; Spirk D; Daemen J; Mach F; Windecker S; Engstrøm T; Lang I; Losdat S; Räber L JAMA Cardiol; 2024 Dec; 9(12):1082-1092. PubMed ID: 39221516 [TBL] [Abstract][Full Text] [Related]
10. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
11. Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland. Lewek J; Sosnowska B; Starostecka E; Konopka A; Gach A; Rutkowska L; Adach W; Mierczak K; Bielecka-Dąbrowa A; Banach M Int J Cardiol; 2025 Jan; 419():132667. PubMed ID: 39442759 [TBL] [Abstract][Full Text] [Related]
12. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease. Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994 [TBL] [Abstract][Full Text] [Related]
13. Treatment for women with postpartum iron deficiency anaemia. Jensen MCH; Holm C; Jørgensen KJ; Schroll JB Cochrane Database Syst Rev; 2024 Dec; 12(12):CD010861. PubMed ID: 39670550 [TBL] [Abstract][Full Text] [Related]
14. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
15. Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study. Masana L; Zambon A; Schmitt CP; Taylan C; Driemeyer J; Cohen H; Buonuomo PS; Alashwal A; Al-Dubayee M; Kholaif N; Diaz-Diaz JL; Maatouk F; Martinez-Hervas S; Mangal B; Löwe S; Cunningham T Lancet Diabetes Endocrinol; 2024 Dec; 12(12):880-889. PubMed ID: 39426393 [TBL] [Abstract][Full Text] [Related]
16. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation. Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138 [TBL] [Abstract][Full Text] [Related]
17. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean. Horey D; Kealy M; Davey MA; Small R; Crowther CA Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547 [TBL] [Abstract][Full Text] [Related]
18. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085 [TBL] [Abstract][Full Text] [Related]
19. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline. Reece D; Imrie K; Stevens A; Smith CA; Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial. Vermeire S; Schreiber S; Rubin DT; D'Haens G; Reinisch W; Watanabe M; Mehta R; Roblin X; Beales I; Gietka P; Hibi T; Hospodarskyy I; Ritter T; Genovese MC; Kwon P; Santermans E; Le Brun FO; Barron R; Masior T; Danese S Lancet Gastroenterol Hepatol; 2024 Dec; ():. PubMed ID: 39637881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]